Gene Query: SAV1

Dataset Description Geneva Score
Role of COP1 on MAP kinase transcriptional output in melanoma 70.55
Expression analysis of primary human monocytes stimulated with an anti-TLR10 mAb (5C2C5) 57.66
The role of the Calcium-Sensing receptor in colorectal cancer 52.29
Insulin induced alterations in chromatin acetylation and transcriptome in triple negative breast cancer cells 48.51
The BCL6 RD2 domain governs commitment of activated B-cells to form germinal centers 43.04
Mitotic stress is an integral part of the oncogene-induced senescence program that promotes multinucleation and cell cycle arrest 42.38
Novel Non-catalytic Substrate-selective p38α-specific MAPK Inhibitors with Endothelial-Stabilizing and Anti-inflammatory Activity 39.17
A role for ZNF598 in post-transcriptional gene regulation 28.82
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_sgrna] 28.05
Nuclear Actin Regulates Inducible Transcription by Enhancing RNA Polymerase II Clustering 26.82
Disruption of the exocyst induces podocyte loss and dysfunction 26.62
Transcriptome analysis-identified long noncoding RNA CRNDE in maintaining endothelial cell proliferation, migration, and tube formation 26.05
Synergy from Gene Expression and Network Mining (SynGeNet) method predicts genotype-specific synergistic drug combinations in melanoma 24.26
Analysis of the polyA+ RNA of LPS-treated human CD14+ monocytes 22.98
Differential RNA-seq analysis comparing APC-defective and APC-restored SW480 colorectal cancer cells 21.2
Acriflavine inhibits the epithelial-to-mesenchymal transition in vitro in liver and pancreatic cancer cells (part of study on PANC1 cells treated with CoCl2) 20.97
Regulation of Lipids is Central to Replicative Senescence 20.25
Effects of Inhibition of CDK8/19 Mediator Kinase by Senexin B in HCT116 cells treated with or without TNF-alpha 19.86
Mitotically associated long non-coding RNA, MANCR regulates cell cycle in triple negative breast cancer cells  19.86
G-quadruplex structures mark human regulatory chromatin 19.4
Tristetraprolin disables prostate cancer maintenance by impairing proliferation and metabolic function 18.77
Prediction of bacterial infection outcome using single cell RNA-seq analysis of human immune cells [sorted population Bulk RNA-seq] 17.87
LncRNA NMR knockdown and overexpression in esophageal squamous cell carcinoma cell lines 17.8
Effect of the knockdown of MLL1 and MLL2 on pediatric high grade glioma 17.64
IDH3a KO RNA-seq 17.41
Identification of the networks that regulate human monocytic myeloid-derived suppressor cell differentiation into inflammatory macrophages 16.92
Proteotranscriptomic profiling of potential E6AP targets in prostate cancer cells 16.66
RNA-Seq Samples of siTFE3 in 8988T PDA Cell Line to Investigate Transcriptional Control of the Autophagy-Lysosome System 16.37
RNA-sequencing analysis for gene expression profiles affected by CASC9 knockdown 15.94
Analysis of Combined Transcriptomes Identifies Gene Modules Differentially Responding to Pathogenic Stimulation in Vascular Smooth Muscle and Endothelial Cells 15.66
IGF2BP3 controls cancer cell invasiveness by modulation RISC function 15.63
AR-independent prostate cancer is sustained through FGF signaling 15.43
Transcriptome response to 4h IL-1b stimulation of primary chondrocytes 15.24
Identification of Resistance Genes to BRAF Inhibitor in Melanoma by piggyBac Transposon Activation Mutagenesis Screen 15.24
microRNA suppresses prostate cancer stem cells and metastasis by inhibiting a cohort of pro-metastasis targets including CD44, Rho GTPases and EZH2 14.8
FOXD3 is a novel tumor suppressor in lung cancer 14.65
Transcriptional control of subtype switching ensures adaptation and growth of pancreatic cancer 14.41
RNA sequencing to compare gene expession in control and PF228-treated hepatic stellate cells 14.37
ARID1A and ARID1B loss in HCT116 cells 13.83
Effect of BRCA1 overexpression on genetic expressions of cervical cancer based on next generation sequencing 13.56
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile [mRNA-Seq] 13.49
Transcriptome analysis of reticulated platelets reveals a prothrombotic profile 13.49
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition [CAGE] 13.48
Enhancement of direct reprogramming from fibroblasts to epithelial lineages by OVOL2-induced mesenchymal-to-epithelial transition 13.48
Polysome-associated mRNA profiling of cancer cells in response to CXCL12 and IGF1 13.46
Genome-wide transcriptome analysis of NIPBL iPSC and commited cardiomyoctes 13.19
Developing a Novel Two-Dimensional Culture System to Enrich Human Prostate Luminal Progenitors That Can Function as a Cell of Origin for Prostate Cancer 13.09
Transcriptome analysis of AGS cells infected with Helicobacter pylori P12 13.0
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens [RNA-Seq] 12.74
Inhibitors of the histone methyltransferases EZH2/1 induce a potent antiviral state and suppress infection by diverse viral pathogens 12.74
Human colon organoids reveal distinct physiologic and oncogenic Wnt responses 12.65
Effect of nuclear IL-33 on gene expression 12.65
Novel Form of JARID2 is Required to Regulate Differentiation in Keratinocytes. 12.26
Single-cell transcription profiling in KS1 patient iPSCs and NPCs 12.24
Neonatal and adult human testis defined at the single-cell level 12.22
Differential expression of genes in HCMV-infected fibroblasts regulated by the purinergic receptor P2Y2. 12.13
MUC1-C Drives Lineage Plasticity in Progression to Neuroendocrine Prostate Cancer 12.06
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 11.98
Transcript abundance in A-T-derived iPSC: Comparing isogenic cells to unrelated individual 11.63
A combinatorial screen of the CLOUD uncovers a synergy targeting the androgen receptor 11.58
Epigenetic Inactivation of Cysteine Dioxygenase Type 1 Contributes to ROS-dependent Progression of Colorectal Cancer 11.46
Transcriptome analysis on TDP43 and SRSF3 downstream genes and binding RNAs in MDA-MB231 cells by Next Generation Sequencing 11.3
Paxillin regulates genomic networks in prostate cancer [LNCaP] 11.02
Effect of mitochondria deficiency on senescence-associated gene expression 10.95
Genome-wide transcriptome profiling of NEDD9-regulated genes using RNA-seq 10.94
RNA sequencing of human mammary epithelial cells 10.91
A transcriptome dataset revealing the molecular features of breast cancer stem cells 10.85
Epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 10.84
Gene expression profiling study by RNA-seq for identifying genes associated with epithelial-mesenchymal transition and acquired resistance to ALK inhibitors 10.84
The β-catenin/CBP-antagonist ICG-001 inhibits pediatric glioma tumorigenicity in a Wnt-independent manner 10.74
Quantitative Analysis of negative control and overexpression-TRIB1 in PC3 and DU145 Transcriptomes 10.67
Gene expression profiling of neural crest progenitor cultures derived from human embryonic stem cells carrying nonsense mutations in the Polycomb gene ASXL1 [HET] 10.31
RNA-seq in transgenic cells 10.3
Transcriptome analysis in Neobractatin treated cells 10.27
Expression level comparison under dividing and quiescent states in human primary fibroblasts 10.24
Effects of human adipose tissue-derived and umbilical cord tissue-derived mesenchymal stem cells in a dextran sulfate sodium-induced mouse model 10.13
Epigenetic Control of Skeletal Development by the Histone Methyltransferase Ezh2 10.07
RNA-Seq from early time points in the kidney differentiation protocol 10.06
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte 10.01
Distinct regulatory programs for Sox9 in transcriptional regulation of the developing mammalian chondrocyte [RNA-seq] 10.01
A sister of NANOG regulates genes expressed in pre-implantation human development 9.9
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference 9.72
Inhibition of DNA methylation promotes breast tumor sensitivity to netrin-1 interference [RNA-Seq] 9.72
Indoxyl sulfate stimulates angiogenesis by regulating reactive oxygen species production via CYP1B1 9.65
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis 9.6
Immune-restricted epigenetic reader SP140 maintains macrophage identity and activation states critical to intestinal homeostasis [RNA-seq] 9.6
Bone marrow-derived and dental pulp-derived human mesenchymal stem cell RNA-Seq 9.59
Differential gene expression of static and intermittent compressive force treated human periodontal ligament cells 9.45
Control of human hemoglobin switching by LIN28B-mediated regulation of BCL11A translation (Ribo-seq, RNA-seq) 9.42
Nucleotide stress induction of HEXIM1 suppresses melanoma by modulating cancer cell-specific gene transcription [RNA-Seq2] 9.35
RNA sequencing of GLO1-depleted MDA-MB-231 breast cancer cells 9.11
Transcription profile analysis of wild type and Irf9-/- human monocytic THP1 cells in response to type I interferons 9.05
Irf9 function in immunity in mouse 9.05
Human iPSC-derived glomeruli provide an advanced model to interrogate podocyte biology and accurately recapitulate podocytopathy 9.03
EZH2 inhibitor-mediated transcriptional profiling in prostate cancer cells [RNA-seq] 9.0
Distinct changes in transcriptional profiles and epigenetic patterns mediated by EZH2 inhibitors in sensitive and insensitive prostate cancer cells 9.0
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.95
Gene activation precedes DNA demethylation in response to infection in human dendritic cells 8.95
Transcriptional changes in pancreatic cancer cells associated with gemcitabine resistance 8.94
Analysis of HPV16 E2 host gene expression using TERT immortalized keratinocytes (NOKs) cell lines and RNA-sequencing 8.91
Transcriptome of EMT induced MCF10A cells by TGFb treatment or SNAIL S6A expression. 8.81
mRNA-sequencing of U87 glioblastoma and DAOY medulloblastoma spheroidal aggregates undergoing electrotaxis 8.78
RNA-seq analysis to identify the genes regulated by p53-SET interplay 8.76
microRNAs with an AAGUGC seed motif constitute an integral part of a signaling network driving NSCLC cell proliferation 8.73
HNF1 regulates critical functions of the human epididymis epithelium. 8.63
HNF1 regulates critical functions of the human epididymis epithelium. [RNA-Seq] 8.63
Identification of mRNAs with reduced ribosomal loading upon knock-down of translation factor DAP5 from hESCs. 8.63
RNA-Seq Analysis of Anacardic Acid Treated MCF7 and MDA-MB-231 Breast Cancer Cell Lines 8.61
RRAD, IL4I1, CDKN1A, and SERPINE1 genes are potentially co-regulated by NF-κB and p53 transcription factors in cells exposed to high doses of ionizing radiation [RNA-Seq] 8.54
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis 8.53
Characterization of transcriptomics landscape in HUVEC cells exposed to oxidative stress (Total RNA) 8.49
A non-catalytic function of carbonic anhydrase IX contributes to the glycolytic phenotype and pH regulation in human breast cancer cells 8.46
Gene expression and 4sUDRB-seq for NF90/NF110 of human scramble and KD HeLa cells. 8.45
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits 8.44
Systematic Functional Dissection of Common Genetic Variation Affecting Red Blood Cell Traits [mRNA-Seq] 8.44
Impact of HypERrlnc Knockdown on the human pericyte transcriptome 8.44
Effect of disulfiram treatment on pediatric high grade glioma 8.4
LNCaP treated with iBET 8.33
Non-transmissible measles virus vector with segmented RNA genome establishes different types of iPSCs from hematopoietic cells 8.28
Patterned human microvascular grafts enable rapid vascularization and increase perfusion in infarcted hearts 8.27
Nuclear Parkin Regulates Transcriptional Response during Hypoxia 8.18
RING-finger protein 6 amplification activates JAK/STAT3 pathway by modifying SHP-1 ubiquitylation and associates with poor outcome in colorectal cancer 8.13
Selective expression of long non-coding RNAs in a breast cancer cell progression model 8.12
Total RNA sequencing of prospective axial stem cell cultures derived from human pluripotant stem cells 8.07
Vitamin C Promotes Apoptosis in Breast Cancer Cells by Increasing TRAIL Expression 7.9
Candidate genes and pathways downstream of PAX8 involved in ovarian high-grade serous carcinoma 7.8
TGFβ-induced fibroblast activation requires persistent and targeted HDAC-mediated gene repression 7.74
RNASEQ Analysis of sh-TRC and sh-MIR100HG in the triplex negative breast cancer 7.73
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 [RNA-Seq] 7.66
LHX9 rescues KRAS suppression through transcriptional regulation of YAP1 7.66
Patient-derived organoids (PDOs) model treatment response of metastatic gastrointestinal cancers. 7.62
Effect of hyper-and hypoactivation of Notch signaling in IL-4-stimulate THP-1 7.61
Food-derived Compounds Apigenin and Luteolin Modulate mRNA Splicing of Introns with Weak Splice Sites 7.61
Resistance to BET inhibitor leads to new therapeutic vulnerabilities in castration resistant prostate cancer 7.59
RNA sequence analysis of stable versus reversible EMT events and the resultant metastases 7.52
mRNA-sequencing of breast cancer subtypes and normal tissue 7.51
Effects of Belinostat and Dexamethasone treatment of A549 gene expression 7.37
Single-cell expression profiling reveals new roles for G-protein-coupled receptors in the regulation of Th17 pathogenicity 7.36
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin (RNA-seq) 7.33
Inherent DNA binding specificities of the HIF-1α and HIF-2α transcription factors in chromatin 7.33
The ATPase module of mammalian SWI/SNF family complexes mediates subcomplex identity and catalytic activity-independent genomic targeting 7.3
The mSWI/SNF ATPase module mediates subcomplex identity and non-catalytic targeting in SCCOHT [RNA-seq] 7.3
Dissection of estrogen receptor alpha signaling pathways in osteoblasts using RNA-sequencing 7.27
Identification of ZEB1-regulated gene expression changes in HCC827 human lung adenocarcinoma cells 7.26
Splicing and gene expression changes in human MDAM-MB231 breast cancer cells with TRA2B knockdown 7.25
Transcriptomic hallmarks of tumor plasticity and stromal interactions in brain metastasis [MultiDisease] 7.23
Gene-Edited Human Kidney Organoids Reveal Mechanisms of Disease in Podocyte Development 7.14
Understanding the Mechanistic Contribution of Herbal Extracts in Compound Kushen Injection with Transcriptome Analysis 7.1
Direct identification of endogenous SMG6 targets and a preferred motif spanning SMG6 cleavage sites by parallel analysis of RNA ends in human cells 7.08
Peroxisome Proliferator-activated Receptor gamma- Deficiency in Endothelial Cells Impairs Angiogenic Capacity by Loss-of E2F1 Mediated Wnt Effector Genes 7.08
Genome-wide analysis of herpes simplex virus type 1 (HSV-1) infected cells 7.01
SPOP mutation confers intrinsic BET inhibitor resistance in prostate cancer (BRD4_JQ1_RNA-seq) 6.99
Targets of CDK12 on ZR-75-30 breast cancer cells (RNA-seq) 6.96
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis [RNA-Seq] 6.92
KMT2D regulates p63 target enhancers to coordinate epithelial homeostasis 6.92
Transcriptome analysis in HT29 and SW480 cells depleted of Prdx2 6.88
mRNA Sequencing of Human PromoCells Using Random Primed mRNA-Sequencing Technique 6.87
Prostaglandin E2 inhibits pro-fibrotic function of human pulmonary fibroblasts by disrupting Ca2+-signaling 6.83
Perivascular signals alter global genomic profile of glioblastoma and response to temozolomide in a gelatin hydrogel 6.8
Tumor exosome integrins determine organotropic metastasis 6.78
ZRANB2 and SYF2 mediated splicing programs converging on ECT2 are involved in breast cancer cell resistance to doxorubicin 6.77
Mammalian Hbs1L deficiency causes Pelota depletion and is associated with a unique phenotype 6.72
RNA-Seq profiling of days 0, 7 and 18 kidney organoids differentiated from three separate vials of starting material 6.71
Nickel induced transcriptional changes persist post exposure through epigenetic reprograming (ChIP-seq & RNA-seq datasets) 6.7
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice 6.62
ARID1A loss impairs enhancer-mediated gene regulation and drives colon cancer in mice [HCT116_RNA-seq] 6.62
Bach1 Regulates the Self-renewal and Mesendodermal Differentiation of Human Embryonic Stem Cells 6.61
Gene expression analysis of ER+ and ER- breast cancer cell lines with acquired resistance to palbociclib 6.53
Nucleoporin-mediated regulation of cell identity genes 6.52
Muscleblind-like 1 suppresses breast cancer metastatic colonization and stabilizes metastasis suppressor transcripts 6.52
MBNL1-dependent modulation of gene expression in MDA-MB-231 breast cancer cells 6.52
Transcriptomic alterations in fibroblasts from Parkinson's disease patients carrying Parkin mutations 6.52
AZ1366: An inhibitor of tankyrase and the canonical Wnt pathway that limits the persistence of non-small cell lung cancer cells following EGFR inhibition 6.45
Transcriptomic analysis of T84 colon carcinoma cell line treated with trametinib, JQ1 or their combination 6.45
Oncogenic Notch promotes long-range regulatory interactions within hyperconnected 3D cliques [MB157_RNA-seq] 6.44
U1 snRNP telescripting regulates size-function stratified human genome 6.44
Selective suppression of endothelial cytokine production by progesterone receptor [RNA-seq] 6.42
Selective suppression of endothelial cytokine production by progesterone receptor 6.42
Differentially expressed vascular development genes for iPSC-ECs from CDI 6.4
RNA-seq of cancer-associated fibroblasts (CAF) treated with PBS or extracellular vesicles (EV) from MCF10A or MDA-MB-231 cells 6.37
Combined Experimental and System-Level Analyses Reveal the Complex Regulatory Network of miR-124 during Human Neurogenesis [ZNF787] 6.28
Isolation and Functional Interrogation of Adult Human Prostate Epithelial Stem Cells at Single Cell Resolution 6.27
RNA sequencing of heart samples of myotonic dystrophic (DM1) patients 6.25
Gene expression data from IMR90 control, IMR90 shRRM2 and shRRM2/shp16 6.2
Messenger RNA profile analysis deciphers new Esrrb responsive genes in prostate cancer cells 6.2
Human gut derived-organoids as model to study gluten response and effects of microbiota bioproducts in celiac disease 6.09
Multidimensional Assessment of the Host Response in Mechanically Ventilated Patients with Suspected Pneumonia 6.02
IgG immunocomplexes sensitize human monocytes for inflammatory hyperactivity via transcriptomic and epigenetic reprogramming in Rheumatoid Arthritis 6.02
Single-cell transcriptome of human epithelial cells reveals novel insights into early innate immune responses to influenza virus and viral antagonism 6.01
DHX15 regulates CMTR1-dependent gene expression and cell proliferation 6.0
Transcriptome analysis of genetically matched human induced pluripotent stem cells disomic or trisomic for chromosome 21 5.98
Identification of differentially expressed genes between senescence and senescence bypass cells 5.86
Human CD11b+ macrophages - Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.85
Aging of hematopoietic stem cells is driven by regional specialization of marrow macrophages 5.85
A role for p53 in the adaptation to glutamine starvation through the expression of Slc1a3 5.82
Oncogenic Antisense LncRNA P14AS Regulates Expression of ANRIL through AUF1 Binding 5.82
MYC dependent mRNA translation shapes gene expression and cell biology 5.79
Single Cell RNA-Sequencing Identifies Diverse Roles of Epithelial Cells in Idiopathic Pulmonary Fibrosis 5.77
Transcriptome analysis of ECFCs treated with GSK-343 and Panobinostat 5.75
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors 5.74
Targeting Taxane-Platin Resistant Lung Cancers with JumonjiC Lysine Demethylase Inhibitors (RNA-Seq) 5.74
Gene expression profiling of human CD19+ B cells and EBV transformed lymphoblastoid cell lines (LCLs) 5.71
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells 5.68
Dioxin and AHR impairs mesoderm gene expression and cardiac differentiation in human embryonic stem cells (RNA-Seq) 5.68
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury 5.65
Comprehensive analysis of Long non-coding RNA expression in dorsal root ganglion reveals cell type specificity and dysregulation following nerve injury [human iPS] 5.65
Knock-down of Ror1 in MDA-MB-231 cell line decreases cell invasiveness 5.65
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer 5.64
UBR7 is a novel E3 ubiquitin ligase for H2BK120 and acts as a tumor-suppressor in breast cancer [RNA-Seq] 5.64
Next-generation sequencing analysis of transcriptom in gemcitabine resistant pancreatic cancer cells 5.64
Electronic cigarettes 5.64
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.57
Interaction with ZMYND11 mediates opposing roles of Ras-responsive transcription factors ETS1 and ETS2 5.57
An epigenetic mark of polycomb response elements implemented by Trx/MLL/COMPASS 5.56
The effect of Abl kinases,or Ponatinib challenging on breast cancer cells' global transcriptome 5.46
Depicting early human development and germ cell origin with porcine embryos 5.45
A bioinformatics approach reveals novel mechanisms of the OVOL transcription factors in the regulation of epithelial-mesenchymal cell programming and cancer progression. 5.43
Inhibition of TNBC metastasis by Gpx1 5.4
RNAseq data from SCCOHT1 and OVCAR8 ovarian cancer cells treated with BET inhibitors 5.4
GREB1 amplifies androgen receptor output in prostate cancer and contributes to antiandrogen resistance 5.4
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells (RNA-Seq) 5.32
ETS1 is a genome-wide effector of RAS/ERK signaling in epithelial cells 5.32
Interleukin-1β induces mitochondrial DAMP production to activate STING-dependent innate immune programs 5.27
Lineage specific differentiation is influenced by state of human pluripotency 5.26
Lineage specific differentiation is influenced by state of human pluripotency [RNA-seq] 5.26
Detailed genomic and molecular characterization of Indian induced pluripotent stem cell lines 5.19
Transcription factors OVOL1 and OVOL2 induce the mesenchymal to epithelial transition in human cancer 5.17
Mechanistic Model-Guided Study of Embryonic Morphogenesis 5.17
Histone H3 lysine 4 acetylation-methylation dynamics define breast cancer subtypes [RNA-seq] 5.14
Histone H3 Lysine4 Acetylation-Methylation Dynamics Define Breast Cancer Subtypes 5.14
RNA sequencing of human macrophages treated with iron chelator deferiprone (DEF), with and without lipopolysaccharide (LPS) 5.13
Codon usage optimization in pluripotent embryonic stem cells [RNA-seq] 5.11
Ribosomal footprinting of MDA_Ctrl and MDA_Arg overexpression cell lines 5.11
Differential susceptibility of human pleural and peritoneal mesothelial cells to asbestos exposure 5.1
Platelet Transcriptome Profiling in HIV and ABCC4 as a Biomarker of Platelet Activity 5.08
Gene expression, methylome and splicing of THP-1 monocytic cells and THP-1-derived macrophage 5.07
Transcriptional profiling of growing and senescent WT and IL-1R-depleted IMR90 cells 5.05
Cleavage Factor Im as a key regulator of 3’ UTR length 5.04
The DNM3OS lncRNA is a reservoir of fibromiRs with major functions in fibroblast response to TGF-beta and fibrogenesis 5.04
RNA-Seq analysis of human lung fibroblasts exposed to TGF-β 5.04
RNA-seq analysis of RALD iPSCs after in vitro differentiation 5.0
Effect of drugs on transcriptomic profiles 4.98
The contribution of adenosine receptor 3-mediated signaling to TLR4-induced responses by human dendritic cells 4.95
Expression data from human perivascular stem cell-derived extracellular vesicles (PSC-EVs) and PSCs 4.94
Ribosome queuing enables non-AUG translation to be resistant to multiple protein synthesis inhibitors 4.94
p38 SAPK and SKIIP induced changes in alternative splicing patterns upon osmostress 4.93
Prolyl Hydroxylase Substrate Adenylosuccinate Lyase Is An Oncogenic Driver In Triple Negative Breast Cancer 4.91
Single-cell transcriptomics of the human retinal pigment epithelium and choroid in health and macular degeneration 4.9
Induction of Prolonged Early G1 Arrest by CDK4/CDK6 Inhibition Reprograms Lymphoma Cells for Durable PI3Kδ Inhibition Through PIK3IP1 4.89
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.87
The ETS transcription factor ELF1 regulates a critical, broadly antiviral program distinct from the type I interferon response 4.87
Implication of Long noncoding RNAs in the endothelial cell response to hypoxia revealed by RNA-sequencing. 4.86
In vitro modeling of human germ cell development using pluripotent stem cells 4.85
A compendium of promoter-centered long-range chromatin interactions in diverse human tissues and cell types 4.85
Transcriptomes of oxLDL exposed trained monocytes 4.84
oxLDL exposed trained monocytes 4.84
Complete deconvolution of cellular mixtures based on linearity of transcriptional signatures 4.82
Disrupted prenatal RNA processing and myogenesis in congenital myotonic dystrophy 4.82
5hmC and gene expression data in breast cancer cell lines treated with an antioxidant 4.81
Distinct regulation of alternative polyadenylation and gene expression by nuclear poly(A) polymerases 4.8
Tumor suppressor SMARCB1 suppresses super-enhancers to govern hESC lineage determination 4.79
Self-organized amniogenesis by human pluripotent stem cells in a biomimetic implantation-like niche 4.79
Human Adipocytes Regulate Gene Expression in Triple-negative Breast Cancer Assessed by NGS Sequencing 4.77
Impact of flanking chromosomal sequences on localization and silencing by the ncRNA XIST 4.76
6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 4 is essential for p53-null cancer cells 4.73
Gene expression profiling in lung and breast cancer cells treated by Bloom-specific siRNAs 4.73
HNF1A deficiency impairs β-cell fate, granule maturation and function 4.73
Cooperation between TLX1 and the NUP214-ABL1/STAT5 signaling in T-cell acute lymphoblastic leukemia 4.73
FMRP facilitates the nuclear export of N6-methyladenosine-containing mRNAs 4.73
Coordinated control of senescence by lncRNA UCA1 and a novel CAPERα/TBX3 co-repressor 4.7
OBESITY IS ASSOCIATED WITH IMPAIRED EXPRESSION OF THE GLYCOSYLTRANSFERASE EOGT IN DECIDUALIZING ENDOMETRIUM 4.7
Transcriptomics of human macrophages upon infection with Legionella pneumophila and two isogenic mutants, LamA and AnkH using RNA-seq 4.68
Developmental origins define epigenomic differences between subcutaneous and visceral adipocytes [RNA_seq_Whole] 4.67
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders 4.66
The novel lncRNA lnc-NR2F1 is pro-neurogenic and mutated in human neurodevelopmental disorders [lnc-Nr2f1 overexpression] 4.66
Random mono-allelic expression in MECP2-mutated cells 4.66
Human Cactin interacts with DHX8 and SRRM2 to assure efficient pre-mRNA splicing and sister chromatid cohesion. 4.62
Differential effects of estrogen receptor beta isoforms on glioblastoma progression 4.51
Transcriptome wide analysis of classically and alternatively activated macrophages 4.5
Effect of from Human Umbilical Vein Endothelial Cells 4.46
Maintaining iron homeostasis is the key role of lysosomal acidity for cell proliferation 4.46
Transcriptional changes in lymphoma cells induced by LSD1 depletion 4.45
Histone demethylase LSD1 is required for germinal center formation and BCL6 driven lymphomagenesis 4.45
Whole Transcriptomic Sequencing of Metastatic Castration Resistant Prostate Cancer Samples 4.42
Transcriptional profile of human STAT1-/- fibroblasts expressing LY6E or empty control vector 4.38
Small-molecule targeting of brachyury transcription factor addiction in chordoma [rnaseq_compound] 4.35
An aspartyl protease defines a novel pathway for export of Toxoplasma proteins into the host cell 4.33
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. Tested on 5 concentrations. 4.31
TGFβ1-mediated functional inhibition of mesenchymal stromal cells in MDS and AML 4.28
Genome-wide CRISPR-Cas9 screen identifies SLC1A3 as a key contributor to L-asparaginase Resistance in Solid tumors 4.28
Global unleashing of transcription elongation waves in response to genotoxic stress restricts somatic mutation rate 4.27
Gene Expression Profiling of SPOP Knocked Down Cell 4.26
SLIGRL-induced gene expression changes in NHEK cells 4.23
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma (RNA-Seq) 4.2
Bromodomain and extraterminal proteins foster the core transcriptional regulatory programs and confer vulnerability in liposarcoma 4.2
Transcriptome of TNF-a-treated and untreated HeLa cells before and after TFIIB knockdown 4.18
Mining the stiffness-sensitive transcriptome in human vascular smooth muscle cells identifies long non-coding RNA stiffness regulators 4.18
The transcriptome of human endometrial mesenchymal stem cells under TGFβR inhibition reveals improved potential for cell-based therapies 4.17
MARS Seq data from human cortical organoids 4.09
Determining effects of microbial metabolite, Urolithin A on colon epithelial cells 4.08
Immune Checkpoint Regulation of Pulmonary Fibrosis [bulk RNA-seq] 4.07
Joint-specific DNA transcriptome signatures in rheumatoid arthritis [RNA-seq] 4.05
Inhibition of Enhancer of Zeste Homologue 2 attenuates TGF-β dependent hepatic stellate cell activation and liver fibrosis 4.04
ZMYND8 reads the dual histone mark H3K4me1-H3K14ac to antagonize the expression of metastasis-linked genes 4.02
Peptidomimetic blockade of MYB in acute myeloid leukemia 3.99
Peptidomimetic blockade of MYB in acute myeloid leukemia [RNA-seq] 3.99
PGE2 mediated gene expression changes in human cervical stromal cells 3.94
Regulation of hypoxia-inducible factor activity by ZMYND8 3.86
Global transcriptome analysis of HAP1 cells 3.84
Coordinate regulation of alternative pre-mRNA splicing events by the human RNA chaperone proteins hnRNPA1 and DDX5 3.82
GIST cell cycle dysregulation is required for progression to high-risk disease but not for resistance to kinase inhibitors 3.81
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency 3.79
Ribosome Incorporation into Somatic Cells Promotes Lineage Transdifferentiation towards Multipotency [RNA-Seq] 3.79
Human muscle-derived CLEC14A-positive cells regenerate muscle independent of PAX7 3.74
Global gene expression analysis of human monocyte-derived dendritic cells (DCs) treated with HMGN1 (N1) and R848 alone or in combination. 3.72
Smad5 acts as an intracellular pH messenger and maintains bioenergetic homoeostasis 3.71
Transcriptome analysis of immature and matured human oocytes from patients of young and advanced maternal age 3.66
Regulation of the glucocorticoid receptor via a BET-dependent enhancer drives antiandrogen resistance in prostate cancer 3.6
Time series single-cell transcriptomic analysis of AEC2 directed differentiation 3.58
APT1 regulates the asymmetric partitioning of Notch and Wnt signaling during cell division 3.57
The cohesin release factor WAPL restricts chromatin loop extension. [RNA-Seq] 3.51
The cohesin release factor WAPL restricts chromatin loop extension. 3.51
Identification of metabolically distinct adipocyte progenitor cells in human adipose tissues 3.49
The histone H3.3K36M mutation reprograms the epigenome of chondroblastomas 3.48
Transcriptomic analysis of cultured isogenic myotonic dystrophy type 1 myoblasts with and without the DMPK CTG repeat 3.44
Sequencing of ponatinib-resistant LC-2/ad derivatives (PR1 and PR2) and parental LC-2/ad cells 3.43
Role of BET proteins in YAP/TAZ-dependent transcription [RNA-seq 2] 3.42
Genome-wide expression analysis of young, senescent and p38MAPK-inhibitited senescent human fibroblasts. 3.4
Small-molecule targeting of brachyury transcription factor addiction in chordoma 3.36
Transcriptome Sequencing of Adipose-Derived Mesechymal Stromal Cells 3.34
Recapitulating and Deciphering Tumor-stroma Microenvironment by Using a “LEGO” like 3D printed microfluidic device 3.32
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis 3.31
Disease Model of GATA4 Mutation Reveals Transcription Factor Cooperativity in Human Cardiogenesis [RNA-Seq] 3.31
SNHG15 is a bifunctional MYC-regulated noncoding locus encoding a lncRNA that promotes cell proliferation, invasion and drug resistance in colorectal cancer by interacting with AIF 3.26
PRDM1 inhibits proliferation of human colon cancer organoids 3.23
Transcriptome Profiling of Human Primary Monocytes 3.23
Noncoding regions are the main source of targetable tumor-specific antigens 3.22
Functional Comparison of the HGF/Met and MSP/Ron Systems in a Pancreatic Cancer Model 3.19
Gene expression profiles of ibrutinib-responsive and ibrutinib non-responsive cells in ERBB4 expressing cancer cell lines 3.19
Knockout of miR-221 and miR-222 reveals overlapping and specific function between paralogous miRNAs 3.18
A MYC/GCN2/eIF2alpha negative feedback loop limits protein synthesis to prevent MYC-dependent apoptosis in colorectal cancer 3.13
RNA-sequencing of mRNAs from control and CAP-D3 deficient Salmonella infected HT-29 cells 3.13
Folliculin regulates mTORC1/2 and WNT pathways in early human pluripotency 3.1
Effect of CRISPR-Cas9 mediated knock-out of integrin alpha2 on the transcriptome of DU145 prostate cancer cell grown as a spheroid culture 3.05
SMYD2 specificly regulate BIX-01294 induced TP53 target genes revealed by RNA-Seq 3.03
Limiting cholesterol biosynthetic flux engages type I IFN signaling in a STING-dependent manner 3.03
An Argonaute phosphorylation cycle promotes microRNA-mediated silencing [polyA RNA-seq] 3.0
The cohesin complex prevents Myc-induced replication stress 2.98
Adaptation of the Kinome Promotes Resistance to BET Bromodomain Inhibitors in Ovarian Cancer 2.95
DRB/GRO-Seq -/+ UV 2.86
FBP2 inhibits sarcoma progression by restraining mitochondrial biogenesis 2.85
Effect of SHP2 inhibition on hepatic stellate cell transcriptome. 2.83
Next-generation RNA sequencing to determine changes in gene expression during breast cancer progression 2.82
Reprogramming of dermal papilla cell intact gene signature with 3D culture and Lef-1 overexpression 2.79
Human Nonsense-Mediated RNA Decay Initiates Widely by Endonucleolysis and Targets snoRNA Host Genes 2.78
6mer seed toxicity in tumour suppressive microRNAs 2.75
Lung adenocarcinoma metastasis is suppressed by the alveolar lineage transcription factors GATA6 and HOPX. 2.67
A NIK-SIX signaling axis controls inflammation by targeted silencing of noncanonical NF-κB 2.66
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation 2.65
H3K36 mutations promote sarcomagenesis through genome-wide remodeling of H3K36 and H3K27 methylation [RNA_Chondroblastoma_H3K36M_H3WT] 2.65
Differential gene expression by suppression of either SOX2 or TP63 in KYSE70 human esophageal squamous carcinoma cell line. 2.65
Gene expression profiling by RNA-seq in hTert-HME1 cell line treated with control or BRCA2 siRNAs and grown with or without EGF (epithelial growth factor) II 2.63
Improving fibroblast characterization using single-cell RNA sequencing: an optimized tissue disaggregation and data processing pipeline 2.6
TFAP2C signalling in human fibroblasts 2.6
TRIM28-Regulated Transposon Repression Is Required for Human Germline Competency and Not Primed or Naive Human Pluripotency 2.58
Induced pluripotent stem cell modeling of bone marrow failure and MDS identifies therapeutic targets 2.58
Transcriptional profiling at the DLK1/MEG3 domain explains clinical overlap between imprinting disorders 2.57
JAK dependent survival of ALK- ALCL 2.57
Effect of BB608 on Gene Expression in HNSCC Cell Line 2.57
Human macrophages exhibit high activity to clear intracellular biovar Microtus strain of Y. pestis 2.52
Structural basis for human respiratory syncytial virus NS1-mediated modulation of host responses 2.49
Flura-seq identifies organ-specific adaptations in metastasis-initiating cells 2.49
Different Temporal Effects of Ebola Virus VP35 and VP24 Proteins on Global Gene Expression in Human Dendritic Cells 2.48
Selective silencing of euchromatic L1s revealed by genome-wide screens for L1 regulators 2.47
Reconstituting development of pancreatic intraepithelial neoplasia from primary human pancreas duct cells 2.44
Transcriptome-wide response to synthetic chromatin protein PcTF 2.43
Structure and degradation of circular RNAs regulate PKR activation in innate immunity 2.31
Pervasive transcription read-through promotes aberrant expression of oncogenes and RNA chimeras in renal carcinoma 2.31
RNA transcriptome sequencing analysis of SGC-7901 cells transfected with tcons_00001221 shRNA or control shRNA 2.29
Identification of alternatively spliced transcripts in brain metastatic derivatives of MDA-MB-231 breast cancer cells in response to RBM47 expression 2.29
The identification of RBM47 binding sites and RBM47-dependent alternative splicing events in brain metastatic breast cancer cells 2.29
RNA G-quadruplexes mark repressive upstream open reading frames in human mRNAs 2.29
Generation of mature lung alveolar epithelial cells from human pluripotent stem cells 2.28
Sequencing of freshly produced RNA following exposure of cells to DNA damage-inducing UV mimetic 4-hydroxyaminoquinolone (4-NQO) 2.28
Chemotherapeutic drugs inhibiting Topoisomerase 1 activity inhibit TNF-induced inflammatory gene expression 2.24
Small extracellular vesicles are key regulators of non-cell autonomous intercellular communication in senescence via the interferon protein, IFITM3 2.22
Gene expression changes due to PARP knockdown in human cells 2.16
Comparative analysis of kidney organoid and adult human kidney single cell and single nucleus transcriptomes 2.16
siRNA-mediated silencing of ORAI3 in MDA-MB-468 breast cancer cells exposed to hypoxia 2.15
RNA sequencing of human pancreatic cancer cell lines 2.13
Mesenchymal stem/stromal cell engulfment reveals metastatic advantage in breast cancer 2.11
Dexamethasone inhibits respiratory syncytial virus-driven mucus production while increasing viral replication without altering antiviral interferon signaling 2.09
mRNA sequencing of oropharyngeal cancer cell lines 2.04
RNA-seq analysis of PRMT5-regulated genes in irradiated/non-irradiated LNCaP cells 2.0
Epigenetic activation and memory at a TGFB2 enhancer in systemic sclerosis 1.97
Microsatellite expansion RNA visualization, elimination, and reversal of molecular pathology by RNA-targeting Cas9 1.95
Gene expression analysis of human liver progenitor-like cells in culture 1.95
Transcriptomic analysis of differential expressed genes of human tonsillar epithelial cells UT-SCC-60B in response to EV71 infection 1.92
Whole-transcriptome profilings between a pair of HCA7-derived KRAS-wildtype cetuximab sensitive and resistant colon cancer cells from 3D culture 1.89
COMBINING BET AND MEK INHIBITORS SYNERGISTICALLY TARGETS NRAS MUTANT MELANOMA 1.88
Transcriptomic analysis of human iPS cells derived from fragile X syndrome patients during neural differentiation 1.81
A genome-wide long noncoding RNA CRISPRi screen identifies PRANCR as a novel regulator of epidermal homeostasis 1.77
RNA-Seq analysis of prostate cancer cell line LNCaP treated with vehicle, androgen, androgen and IMTPPE, androgen and JJ-(+)-450, androgen and JJ-(-)450, androgen and enzalutamide 1.74
Transcriptome profiling of omental adipose tissues in human obesity by RNA-Seq 1.7
Treatment of prostate cancer cells with S-adenosylmethionine leads to genomewide alterations of transcription profiles 1.69
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug [human] 1.61
Neuronal deletion of Gtf2i, associated with Williams syndrome, causes behavioural and myelin alterations rescuable by a remyelinating drug 1.61
RNA sequencing to study transcriptomic changes in DLD-1 (colorectal adenocarcinoma) cells exposed to soft polyacrylamide matrices (~2 kPa and ~55 kPa) for short time scale of 90 minutes 1.57
Comparative gene expression profiling of human primary endotheliocytes cultivated on polyurethane-based electrospun 3D matrices and natural decellularized vein 1.57
Control of gene expression in senescence through transcriptional read-through of convergent protein-coding genes 1.57
JunB control of keratinocyte-mediated inflammation [RNA-seq] 1.53
RNA-Seq and ChIP-Seq reveals SQSTM1/p62 as a key mediator of JunB suppression of NF-kB-dependent inflammation 1.53
NGS based identification of GD2-positive tumor-specific phenotype for cancer diagnostics and therapy 1.53
Unbiased evaluation of cell-free amniotic fluid transcriptome of term and preterm infants to detect fetal maturity 1.49
Antibiotics induce polarization of pleural macrophages to M2-like phenotype in patients with tuberculous pleuritis 1.48
Next Generation Sequencing Facilitates Quantitative Analysis of Wild Type and SMAD4 Y95 Mutation Transcriptomes 1.42
Transcriptional landscape changes during human embryonic stem cell derivation 1.35
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells 1.27
UTX and 53BP1 co-regulate genetic programs for neural differentiation of human embryonic stem cells [RNA-seq] 1.27
HMGA1 and FOXM1 synergistically regulate a common gene network modulating angiogenesis in breast cancer 1.25
Folate modulation induces chromosomal instability and higher proliferation of immortalized human keratinocytes 1.23
C19ORF66 broadly escapes viral-induced endonuclease cleavage and restricts Kaposi’s Sarcoma Associated Herpesvirus (KSHV) 1.18
Impact of Escherichia coli K12 and O18 on human platelets: effects on platelet activation, spliced platelet RNAs and proteins 1.17
Transcriptome profiling of H1-iCas9 cells grown on laminin and on MEFs 1.13
Human naïve pluripotent stem cells exhibit X chromosome dampening and X-inactivation (RNA-Seq) 1.07
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence [RNA-seq] 1.03
Histone acetyltransferase p300 induces de novo super-enhancers to drive cellular senescence 1.03
Expression profiling of etoposide-induced senescent cells 1.03
Gene expression profiles of brain endothelial cells during embryonic development at bulk and single-cell levels 1.02
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection [RNA-seq] 0.97
Adenovirus Small E1A Employs the Lysine Acetylases p300/CBP and Tumor Suppressor Rb to Repress Select Host Genes and Promote Productive Virus Infection 0.97
Transcriptome profiling of the interconnection of pathways involved in malignant transformation and response to hypoxia 0.97
Transcriptome profiling of de-differentiated chondrocytes over-expressing miR-138 or miR-181ab1 during osteogenic induction 0.94
6mer seed toxicity in viral microRNAs 0.94
Genome-scale screens identify JNK/JUN signaling as a barrier for pluripotency exit and endoderm differentiation 0.9
Translating transcriptome of cancer cells in situ in mesenchymal-rich tumor microenvironment 0.87
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes 0.87
Epigenetic modulation of β-cells by interferon-α via PNPT11-miR-26a-TET2 triggers autoimmune diabetes [RNA-seq] 0.87
Gene expression profiling associated with knockdown of RNF20 in human normal and malignant lung epithelial cell lines 0.82
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene 0.76
Integrative vascular endothelial cell genomics identify AIDA as a coronary artery disease candidate gene (RNAseq) 0.76
Primate-specific gene TMEM14B promotes cortical expansion and folding 0.76
RNA-seq reveals abundant circRNA, lncRNA and mRNA in blood exosomes of patients with colorectal carcinoma 0.7
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. 0.69
Direct in vivo evidence for B-cell receptor and NF-KB activation in mantle cell lymphoma: role of the lymph node microenvironment and activating mutations. [RNA-Seq] 0.69
Does osteogenic potential of clonal human bone marrow mesenchymal stem/stromal cells correlate with their vascular supportive ability? 0.64
Expression changes in MAPKi resistant M229 melanoma lines co-cultured with PD-1 overexpressing HEK293T cells [CellLine.FPKM.batch5] 0.64
RNA-sequencing of epicardial adipose tissue of patients with atrial fibrillation 0.62
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination (RNAseq) 0.61
Response of triple negative breast cancer to BAZ2A/B inhibition and BET bromodomain inhibition alone and in combination 0.61
Identification of biomarkers for amyotrophic lateral sclerosis by comprehensive analysis of exosomal mRNAs in human cerebrospinal fluid. 0.58
The transcription and translation landscapes during human cytomegalovirus infection reveal novel host-pathogen interactions 0.58
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype 0.55
Cancer Associated Fibroblasts are defined by a core set of epigenome changes that contribute to the tumor phenotype [RNA-seq] 0.55
RNA-seq analysis upon ARID1B overexpression 0.54
β-catenin/Tcf7l2 dependent transcriptional regulation of GLUT1 gene expression by Zic family proteins in colon cancer 0.53
YTHDF1 Amplifies Wnt/β-Catenin Signaling to Promote Intestinal Stemness 0.53
Highly-motile versus unsorted MDA-MB-231 breast cancer cells 0.53
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis [RNA-Seq] 0.52
Androgen receptor programming in human tissue implicates HOXB13 in prostate pathogenesis 0.52
Immunophenotyping and Transcriptomic Outcomes in PDX-Derived TNBC Tissue 0.5
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in Chronic Lymphocytic Leukemia 0.49
Identification of grade and origin specific cell populations in serous epithelial ovarian cancer by single cell RNA-seq 0.49
RNA-Seq of human PDA cell lines transfected with control siRNA or Pdx1 siRNA 0.48
Tunable protein synthesis by transcript isoforms in human cells (Transcript Isoforms in Polysomes sequencing: TrIP-seq) 0.48
RNA-Seq of SLNCR1 over-expression in the melanoma cell line A375 0.47
Novel SF3B1 Deletion Mutations Result in Aberrant RNA Splicing in CLL Patients 0.45
A transcriptional regulatory network connects mitochondrial biogenesis and metabolic shift with stem cell commitment to hepatic differentiation 0.43
Gene expression activation in CLL mediated by MSCs contact 0.42
Tri-mannose grafting of chitosan nanocarriers remodels the macrophage response to bacterial infection 0.41
Differential gene expression in Jagged1 treated human dental pulp cells. 0.4
Genome-wide Circadian Control of Transcription at Active Enhancers Regulates Insulin Secretion and Diabetes Risk 0.38
Pancreatic Beta Cell Enhancers Regulate Rhythmic Transcription of Exocyst Triggering and Diabetes 0.38
Melanoma therapeutic strategies that select against resistance by exploiting MYC-driven evolutionary convergence 0.37
Genome-wide expression analysis of human hTert immortalized fibroblasts after downregulation of MCM2 & MCM7 0.37
Expression profiling of pancreatic adenocarcinoma and ductal adenocarcinoma cell lines. 0.36
Class I histone deacetylases HDAC1, 2 and 3 are histone decrotonylases 0.33
Gene expression profile of CRC-derived HILEC 0.32
Activation Dynamics and Immunoglobulin Evolution of Pre-existing and Newly Generated Human Memory B-cell Responses to Influenza Hemagglutinin 0.32
WNT signaling memory is required for ACTIVIN to function as a morphogen 0.31
KSDM1b Role in Ewing Sarcoma 0.3
Deep sequencing of transcript levels of human embryonic stem cell derived mesothelium (epithelial and mesenchymal forms) and mesothelium from neonatal mouse E15.5 of the heart, lung, liver and gut and ChIP-seq data of the mesenchymal form of mesothelium 0.25
Modulation of nonsense-mediated decay by rapamycin 0.24
Transcriptomic analysis of senescent cells upon EXOC7 knockdown. 0.2
Decoding breast cancer tissue-stroma interactions using species-specific sequencing 0.19
ELP1 splicing correction reverses proprioceptive sensory loss in familial dysautonomia 0.15
RNA-seq from primary skin fibroblasts, derived of matched pairs of middle and late donor age 0.12
Aging signatures developed from a longitudinal study design are dominated by reduced transcription of genes involved in protein synthesis. 0.12
Arnica montana stimulates extracellular matrix gene expression in human macrophages differentiated to wound-healing phenotype. 0.11
EGR1-controlled transcriptome of T HESCs 0.1
RNA sequencing of hiPSC derived neural crest populations from Familial Dysautonomia patients 0.09
Hyperactive mTOR and MNK1 phosphorylation of eIF4E confer tamoxifen resistance and estrogen independence through selective mRNA translation reprogramming 0.08
Tissue-specific RNA-seq in human evoked inflammation identifies novel blood and adipose lincRNA signatures of cardio-metabolic diseases 0.08
RNA-Seq and expression data from human adipose tissue 0.08
Gene expression and splicing alterations analyzed by high throughput RNA sequencing of chronic lymphocytic leukemia specimens 0.07
Differential LINE-1 retrotransposition in induced pluripotent stem cells between humans and great apes 0.06
BMS-470539 on human synovial fibroblasts 0.05
Group A Streptococcus M1T1 Intracellular Infection of Primary Tonsil Epithelial Cells Dampens Levels of Secreted IL-8 Through the Action of SpyCEP 0.04
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways 0.01
Altered Hydroxymethylation is seen at regulatory regions in pancreatic cancer and regulates oncogenic pathways [RNA-seq] 0.01


Contact Us

For scientific and technical queries contact Butte Lab @UCSF


Cite GENEVA Tool

Manuscript in Preparation